カテゴリ： GlobalData, 医療/バイオ

高悪性度神経膠腫治療薬の世界市場：治験レビュー

◆英語タイトル：High-Grade Glioma Global Clinical Trials Review, H2, 2019
◆商品コード：GDT20FB0083
◆発行会社（リサーチ会社）：GlobalData
◆発行日：2019年12月
◆ページ数：269
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥275,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD5,000 ⇒換算￥550,000見積依頼/購入/質問フォーム
Enterprisewide Price（複数事業所内共有可）USD7,500 ⇒換算￥825,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

 【レポートの概要】

High-Grade Glioma Global Clinical Trials Review, H2, 2019
Summary

GlobalData’s clinical trial report, “High-Grade Glioma Global Clinical Trials Review, H2, 2019″ provides an overview of High-Grade Glioma clinical trials scenario. This report provides top line data relating to the clinical trials on High-Grade Glioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of High-Grade Glioma to Oncology Clinical Trials 17
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of High-Grade Glioma to Oncology Clinical Trials 21
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 28
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in High-Grade Glioma Therapeutics Clinical Trials 33
Prominent Drugs 35
Latest Clinical Trials News on High-Grade Glioma 36
Nov 08, 2019: Tocagen highlights Toca 6 phase 1b data at Society for Immunotherapy of Cancer Annual Meeting 36
Clinical Trial Profile Snapshots 37
Appendix 273
Abbreviations 273
Definitions 273
Research Methodology 274
Secondary Research 274
About GlobalData 275
Contact Us 275
Disclaimer 275
Source 276

List of Tables
High-Grade Glioma Therapeutics, Global, Clinical Trials by Region, 2019* 8
High-Grade Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
High-Grade Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
High-Grade Glioma Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
High-Grade Glioma Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
High-Grade Glioma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019* 15
High-Grade Glioma Therapeutics Clinical Trials, Central and South America, Top Countries, 2019* 16
Proportion of High-Grade Glioma to Oncology Clinical Trials, G7 Countries (%), 2019* 17
High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
Proportion of High-Grade Glioma to Oncology Clinical Trials, E7 Countries (%), 2019* 21
High-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22
High-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23
High-Grade Glioma Therapeutics, Global, Clinical Trials by Phase, 2019* 24
High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 25
High-Grade Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2019* 27
High-Grade Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2019* 28
High-Grade Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 29
High-Grade Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 30
High-Grade Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 32
High-Grade Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 34
High-Grade Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 35

List of Figures
High-Grade Glioma Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
High-Grade Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
High-Grade Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
High-Grade Glioma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
High-Grade Glioma Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
High-Grade Glioma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019* 15
High-Grade Glioma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2019* 16
Proportion of High-Grade Glioma to Oncology Clinical Trials, G7 Countries (%), 2019* 17
High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
Proportion of High-Grade Glioma to Oncology Clinical Trials, E7 Countries (%), 2019* 21
High-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22
High-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23
High-Grade Glioma Therapeutics, Global, Clinical Trials by Phase (%), 2019* 24
High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 25
High-Grade Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2019* 26
High-Grade Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2019* 28
High-Grade Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 29
High-Grade Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 30
High-Grade Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 31
High-Grade Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 33
High-Grade Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 35
GlobalData Methodology 274

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[高悪性度神経膠腫治療薬の世界市場：治験レビュー]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 悪性神経膠腫治療薬の世界市場：治験レビュー
    GDT20FB0001 / GlobalData / 2019年12月 / ...Malignant Glioma Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Malignant Glioma Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Malignant Glioma clinical trials scenario. This report provides top line data relating to the clinical trials on Malignant Glioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials)....
  2. 骨髄線維症治療薬の世界市場：治験レビュー
    GDT20FB0127 / GlobalData / 2020年1月 / ...Myelofibrosis Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Myelofibrosis Global Clinical Trials Review, H1, 2020" provides an overview of Myelofibrosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Myelofibrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are...
  3. 甲状腺癌治療薬の世界市場：治験レビュー
    GDT20FB0095 / GlobalData / 2020年1月 / ...Thyroid Cancer Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Thyroid Cancer Global Clinical Trials Review, H1, 2020" provides an overview of Thyroid Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Thyroid Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  4. 骨転移治療薬の世界市場：治験レビュー
    GDT20FB0015 / GlobalData / 2019年12月 / ...Bone Metastasis Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Bone Metastasis Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Bone Metastasis clinical trials scenario. This report provides top line data relating to the clinical trials on Bone Metastasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials)....
  5. 卵管がん治療薬の世界市場：治験レビュー
    GDT20FB0056 / GlobalData / 2019年12月 / ...Fallopian Tube Cancer Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Fallopian Tube Cancer Global Clinical Trials Review, H2, 2019" provides an overview of Fallopian Tube Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Fallopian Tube Cancer . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on...
  6. 胃食道(GE)接合部癌治療薬の世界市場：治験レビュー
    GDT20FB0002 / GlobalData / 2019年12月 / ...Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Gastroesophageal (GE) Junction Carcinomas clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroesophageal (GE) Junction Carcinomas. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for...
  7. 悪性星状細胞腫治療薬の世界市場：治験レビュー
    GDT20FB0122 / GlobalData / 2020年1月 / ...Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2020" provides an overview of Anaplastic Astrocytoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Anaplastic Astrocytoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  8. T細胞白血病治療薬の世界市場：治験レビュー
    GDT20FB0077 / GlobalData / 2019年12月 / ...T-Cell Leukemia Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “T-Cell Leukemia Global Clinical Trials Review, H2, 2019" provides an overview of T-Cell Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on T-Cell Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  9. 脳腫瘍治療薬の世界市場：治験レビュー
    GDT20FB0109 / GlobalData / 2020年1月 / ...Brain Tumor Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Brain Tumor Global Clinical Trials Review, H1, 2020" provides an overview of Brain Tumor Clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Tumor. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  10. 直腸がん治療薬の世界市場：治験レビュー
    GDT20FB0065 / GlobalData / 2019年12月 / ...Rectal Cancer Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Rectal Cancer Global Clinical Trials Review, H2, 2019" provides an overview of Rectal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Rectal Cancer Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆